Edward Rudnic is the founder of Dispersol Technologies. Dispersol Technologies has raised $27M in total funding. Latest round: Series A.
Dr. Edward M. Rudnic is the CEO of DisperSol Technologies, a clinical-stage drug development company. He has guided the company through several financing rounds, including a $27 million equity round in 2018. Previously, he worked at Omorphos Therapeutics, where he was involved in raising nearly $200 million through private and IPO financings.
Full founder directory · Investor directory · Company funding database · Fundraising library